213 related articles for article (PubMed ID: 14767534)
1. Evidence that long-term COX-treatment improves energy homeostasis and body composition in cancer patients with progressive cachexia.
Lundholm K; Daneryd P; Körner U; Hyltander A; Bosaeus I
Int J Oncol; 2004 Mar; 24(3):505-12. PubMed ID: 14767534
[TBL] [Abstract][Full Text] [Related]
2. Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care--correlations with food intake, metabolism, exercise capacity, and hormones.
Fouladiun M; Körner U; Bosaeus I; Daneryd P; Hyltander A; Lundholm KG
Cancer; 2005 May; 103(10):2189-98. PubMed ID: 15822132
[TBL] [Abstract][Full Text] [Related]
3. Protection of metabolic and exercise capacity in unselected weight-losing cancer patients following treatment with recombinant erythropoietin: a randomized prospective study.
Daneryd P; Svanberg E; Körner U; Lindholm E; Sandström R; Brevinge H; Pettersson C; Bosaeus I; Lundholm K
Cancer Res; 1998 Dec; 58(23):5374-9. PubMed ID: 9850068
[TBL] [Abstract][Full Text] [Related]
4. Palliative nutritional intervention in addition to cyclooxygenase and erythropoietin treatment for patients with malignant disease: Effects on survival, metabolism, and function.
Lundholm K; Daneryd P; Bosaeus I; Körner U; Lindholm E
Cancer; 2004 May; 100(9):1967-77. PubMed ID: 15112279
[TBL] [Abstract][Full Text] [Related]
5. Weight loss and low body cell mass in males with lung cancer: relationship with systemic inflammation, acute-phase response, resting energy expenditure, and catabolic and anabolic hormones.
Simons JP; Schols AM; Buurman WA; Wouters EF
Clin Sci (Lond); 1999 Aug; 97(2):215-23. PubMed ID: 10409477
[TBL] [Abstract][Full Text] [Related]
6. Insulin treatment in cancer cachexia: effects on survival, metabolism, and physical functioning.
Lundholm K; Körner U; Gunnebo L; Sixt-Ammilon P; Fouladiun M; Daneryd P; Bosaeus I
Clin Cancer Res; 2007 May; 13(9):2699-706. PubMed ID: 17473202
[TBL] [Abstract][Full Text] [Related]
7. Leucine kinetics in patients with benign disease, non-weight-losing cancer, and cancer cachexia: studies at the whole-body and tissue level and the response to nutritional support.
Shaw JH; Humberstone DA; Douglas RG; Koea J
Surgery; 1991 Jan; 109(1):37-50. PubMed ID: 1984636
[TBL] [Abstract][Full Text] [Related]
8. Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supplement.
Barber MD; McMillan DC; Preston T; Ross JA; Fearon KC
Clin Sci (Lond); 2000 Apr; 98(4):389-99. PubMed ID: 10731472
[TBL] [Abstract][Full Text] [Related]
9. Effects of medroxyprogesterone acetate on food intake, body composition, and resting energy expenditure in patients with advanced, nonhormone-sensitive cancer: a randomized, placebo-controlled trial.
Simons JP; Schols AM; Hoefnagels JM; Westerterp KR; ten Velde GP; Wouters EF
Cancer; 1998 Feb; 82(3):553-60. PubMed ID: 9452274
[TBL] [Abstract][Full Text] [Related]
10. Results of a pilot study of the effects of celecoxib on cancer cachexia in patients with cancer of the head, neck, and gastrointestinal tract.
Lai V; George J; Richey L; Kim HJ; Cannon T; Shores C; Couch M
Head Neck; 2008 Jan; 30(1):67-74. PubMed ID: 17615567
[TBL] [Abstract][Full Text] [Related]
11. Effects by daily long term provision of ghrelin to unselected weight-losing cancer patients: a randomized double-blind study.
Lundholm K; Gunnebo L; Körner U; Iresjö BM; Engström C; Hyltander A; Smedh U; Bosaeus I
Cancer; 2010 Apr; 116(8):2044-52. PubMed ID: 20186829
[TBL] [Abstract][Full Text] [Related]
12. Cancer cachexia: measured and predicted resting energy expenditures for nutritional needs evaluation.
Johnson G; Sallé A; Lorimier G; Laccourreye L; Enon B; Blin V; Jousset Y; Arnaud JP; Malthièry Y; Simard G; Ritz P
Nutrition; 2008 May; 24(5):443-50. PubMed ID: 18359195
[TBL] [Abstract][Full Text] [Related]
13. Blockade of tumour necrosis factor-alpha in rheumatoid arthritis: effects on components of rheumatoid cachexia.
Metsios GS; Stavropoulos-Kalinoglou A; Douglas KM; Koutedakis Y; Nevill AM; Panoulas VF; Kita M; Kitas GD
Rheumatology (Oxford); 2007 Dec; 46(12):1824-7. PubMed ID: 18032540
[TBL] [Abstract][Full Text] [Related]
14. Resting energy expenditure and fuel metabolism following laparoscopic adjustable gastric banding in severely obese women: relationships with excess weight lost.
Galtier F; Farret A; Verdier R; Barbotte E; Nocca D; Fabre JM; Bringer J; Renard E
Int J Obes (Lond); 2006 Jul; 30(7):1104-10. PubMed ID: 16477271
[TBL] [Abstract][Full Text] [Related]
15. The effects of non-selective, preferential-selective and selective COX-inhibitors on the growth of experimental and human tumors in mice related to prostanoid receptors.
Cahlin C; Gelin J; Andersson M; Lönnroth C; Lundholm K
Int J Oncol; 2005 Oct; 27(4):913-23. PubMed ID: 16142306
[TBL] [Abstract][Full Text] [Related]
16. Influence of whole body protein turnover rate on resting energy expenditure in patients with cancer.
Fearon KC; Hansell DT; Preston T; Plumb JA; Davies J; Shapiro D; Shenkin A; Calman KC; Burns HJ
Cancer Res; 1988 May; 48(9):2590-5. PubMed ID: 3356019
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the energy balance in lung cancer patients.
Staal-van den Brekel AJ; Schols AM; ten Velde GP; Buurman WA; Wouters EF
Cancer Res; 1994 Dec; 54(24):6430-3. PubMed ID: 7987838
[TBL] [Abstract][Full Text] [Related]
18. Daily physical-rest activities in relation to nutritional state, metabolism, and quality of life in cancer patients with progressive cachexia.
Fouladiun M; Körner U; Gunnebo L; Sixt-Ammilon P; Bosaeus I; Lundholm K
Clin Cancer Res; 2007 Nov; 13(21):6379-85. PubMed ID: 17975150
[TBL] [Abstract][Full Text] [Related]
19. Changes in body mass, energy balance, physical function, and inflammatory state in patients with locally advanced head and neck cancer treated with concurrent chemoradiation after low-dose induction chemotherapy.
Silver HJ; Dietrich MS; Murphy BA
Head Neck; 2007 Oct; 29(10):893-900. PubMed ID: 17405169
[TBL] [Abstract][Full Text] [Related]
20. Role of cytokines and testosterone in regulating lean body mass and resting energy expenditure in HIV-infected men.
Roubenoff R; Grinspoon S; Skolnik PR; Tchetgen E; Abad L; Spiegelman D; Knox T; Gorbach S
Am J Physiol Endocrinol Metab; 2002 Jul; 283(1):E138-45. PubMed ID: 12067854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
